Research project

Dr Cragg Leukaemia Research Fund - Ref 07048: Mechanism of In-Vivo Synergy betwen Anti-CD20 Antibodies and Chemotherapy

Staff

Lead researchers

Professor Mark Cragg

Professor in Experimental Cancer Biology

Research interests

  • Antibody biology
  • Antibody engineering
  • Cancer Immunotherapy
Connect with Mark

Research outputs